Peripheral Mechanisms of Humoral Immune Effector-mediated Tourette's Syndrome and the Role of Tuina Intervention
Conditions: Tourette Syndrome in Children; Food Intolerance; Inflammatory Response Interventions: Other: Spine manipulation; westren medicine Sponsors: The First Affiliated Hospital of Zhejiang Chinese Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome
Conditions: Tourette ' s Syndrome Interventions: Device: Deep Brain Stimulation (DBS) Sponsors: Xuanwu Hospital, Beijing Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Gemlapodect in Adults and Adolescents With Tourette Syndrome
Conditions: Tourette Syndrome Interventions: Drug: Gemlapodect; Drug: Placebo Sponsors: Noema Pharma AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Internet-based Behavior Therapy for Adults With Tourette Syndrome
Conditions: Tourette Syndrome; Chronic Tic Disorder Interventions: Behavioral: Exposure with response prevention; Behavioral: Brief psychoeducation with general psychological support Sponsors: Karolinska Institutet Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics
Conditions: Tourette Syndrome; Persistent Tic Disorder Interventions: Other: CBIT Sponsors: University of Minnesota Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome
Conditions: Tourette Syndrome Interventions: Diagnostic Test: Rathus Assertiveness scale Sponsors: University Hospital, Clermont-Ferrand Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Conditions: Neurodevelopmental Disorders; Autism; Autism Spectrum Disorder; Fragile X Syndrome; Tuberous Sclerosis; 22Q11 Deletion Syndrome; 22Q11 Deletion; ADHD; Tic Disorders; Tourette Syndrome; Tourette Syndrome in Children; Tourette Syndrome in Adolescence; ADHD - Combined Type; ADHD Predominantly Inattentive Type; ADHD, Predominantly Hyperactive - Impulsive; Provisional Tic Disorder; Anxiety; Anxiety Disorders; Agoraphobia; Generalized Anxiety; Generalized Anxiety Disorder; Social Anxiety; Social Anxiety Disorder; Unspecified Anxiety Disorder; Other Specified Anxiety Disorders; Separation Anxiety Interventions: Drug: ...
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Objective Characterizatoion of Repetitive Behaviors
Conditions: OCD; Tic Disorders; Gilles de la Tourette Syndrome Interventions: Device: EEG; Device: MRI Sponsors: Institut National de la Sant é Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
SciSparc Announces Initiation of Randomized Phase IIb Clinical Trial of its Proprietary SCI-110 for Tourette Syndrome
TEL AVIV, Israel, Sept. 08, 2023. SciSparc Ltd. ( " Company " or " SciSparc " ), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, today... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 9, 2023 Category: Pharmaceuticals Source Type: clinical trials
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
Condition: Tourette Syndrome Intervention: Drug: Ecopipam Sponsor: Emalex Biosciences Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
